Inventor · disambiguated record
Kendra N. Avery
Also filed as: AVERY KENDRA · AVERY KENDRA N · AVERY KENDRA NICOLE
9 granted patents·7 pending applications·141 citations·filing 2012–2025
88Inventor score
Top patents by PatentIndex Score
16 records- 0196US10357571B2Development of masked therapeutic antibodies to limit off-target effectsHOPE CITY·Filed 2015·Granted Jul 23, 2019·18 cites·8 claims
- 0296US8962804B2Meditopes and meditope-binding antibodies and uses thereofWILLIAMS JOHN C·Filed 2012·Granted Feb 24, 2015·96 cites·22 claims
- 0392US12398207B2Heterodimeric antibodies that bind CD3 and CLDN6XENCOR INC·Filed 2024·Granted Aug 26, 2025·1 cites·4 claims
- 0491US9193791B2Development of masked therapeutic antibodies to limit off-target effectsWILLIAMS JOHN C·Filed 2012·Granted Nov 24, 2015·11 cites·4 claims
- 0590US9669108B2Meditopes and meditope-binding antibodies and uses thereofHOPE CITY·Filed 2014·Granted Jun 6, 2017·9 cites·8 claims
- 0681US11311622B2Development of masked therapeutic antibodies to limit off-target effectsHOPE CITY·Filed 2019·Granted Apr 26, 2022·1 cites·5 claims
- 0781US9428553B2Meditopes and meditope-binding antibodies and uses thereofHOPE CITY·Filed 2013·Granted Aug 30, 2016·4 cites·15 claims
- 0878US11246942B2Meditopes and meditope-binding antibodies and uses thereofHOPE CITY·Filed 2017·Granted Feb 15, 2022·1 cites·7 claims
- 0977US2024228608A9Heterodimeric antibodies that bind cd3 and cldn6XENCOR INC·Filed 2023·Application pending·0 cites
- 1076US11739144B2Heterodimeric antibodies that bind CD3 and CLDN6XENCOR INC·Filed 2022·Granted Aug 29, 2023·0 cites·5 claims
- 1176US2023085485A1Design and development of masked therapeutic antibodies to limit off-target effectsHOPE CITY·Filed 2022·Application pending·0 cites
- 1274US2023001003A1Meditopes and meditope-binding antibodies and uses thereofHOPE CITY·Filed 2021·Application pending·0 cites
- 1366US2025084179A1Anti-cd28 x anti-trop2 antibodiesXENCOR INC·Filed 2024·Application pending·0 cites
- 1466US2025243279A1Bispecific antibodies that bind to nkp46 and mica/bXENCOR INC·Filed 2024·Application pending·0 cites
- 1560US2023151095A1Bispecific antibodies that bind to b7h3 and nkg2dXENCOR INC·Filed 2022·Application pending·0 cites
- 1653US2025361311A1Anti-tnf-like ligand 1a (tl1a) antibodiesXENCOR INC·Filed 2025·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →